14. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie
Gesellschaft für Arzneimittelforschung und Arzneimittelepidemiologie
15.11. - 16.11.2007, Frankfurt am Main
Posters
Meeting Abstract
(07gaa18)
[Full Text]
Results of observational study CHANGE: prophylaxis and therapy of surgery-related complications in orthopaedic and trauma surgery
Bauersachs R, Berger K, Hankowitz J, Langenberg K, Marzi I, Schramm W[Full Text]
Meeting Abstract
(07gaa19)
[Full Text]
Drug-induced haematotoxicity – new safety signals from the Pharmacovigilance Center Berlin (PVZ – FAKOS)
Bronder E, Andersohn F, Klimpel A, Thomae M, Garbe E[Full Text]
Meeting Abstract
(07gaa20)
[Full Text]
Simulation of the short and long term health and economic impact of a quadrivalent HPV (6,11,16,18) vaccine in Germany
Büsch K, Largeron N[Full Text]
Meeting Abstract
(07gaa21)
[Full Text]
Co-medication in patients with antidepressant therapy under real life conditions – analysis of a German claims database
Gothe H, Höer A, Volmer T, Runge C, Glaeske G, Häussler B[Full Text]
Meeting Abstract
(07gaa22)
[Full Text]
Use of Fondaparinux for long term prophylaxis in high risk patients with history of HIT (heparin-induced thrombocytopenia)
Grellmann G, Oehmichen F, Pohl M, Hankowitz J[Full Text]
Meeting Abstract
(07gaa23)
[Full Text]
Use of Fondaparinux for long term prophylaxis in high risk patients requiring artifical ventilation: results of a quality management survey
Grellmann G, Oehmichen F, Pohl M, Hankowitz J[Full Text]
Meeting Abstract
(07gaa24)
[Full Text]
Representative monitoring on consumption of antibiotics in livestock
Hajek P, Merle R, Ungemach FR, Kreienbrock L[Full Text]
Meeting Abstract
(07gaa25)
[Full Text]
Prevention of hospitalisation by identification of subjects at risk using a medication-based algorithm: a feasibility study
Harder S, Kurepkat M, Fleckenstein J[Full Text]
Meeting Abstract
(07gaa26)
[Full Text]
Estimation of costs and long-term outcomes of the treatment with insulin glargine plus oral antidiabtics (BOT) compared to twice daily premixed insulin (CT) based on the LAPTOP Trial
Janka HU, Hessel F, Müller E[Full Text]
Meeting Abstract
(07gaa27)
[Full Text]
Secondary medical prevention of acute coronary syndromes: a six-months follow-up study
Loeffert S, Thuem S, Pfaff H[Full Text]
Meeting Abstract
(07gaa28)
[Full Text]
A database to identify drug risks in pregnancy?
Scharnetzky E, Pigeot I, Ahrens W, Garbe E[Full Text]
Meeting Abstract
(07gaa29)
[Full Text]
Methods of intervention by health insurance companies, illustrated by the example of covering letters written to physicians
Schicktanz C, Glaeske G[Full Text]
Meeting Abstract
(07gaa30)
[Full Text]
Change of drug therapy in the treatment of diabetics through Disease Management Programs (DMP)
Staffeldt T, Kampmann C, Grossmann A[Full Text]